Scorpius Holdings, Inc. (SCPX) — SEC Filings
Scorpius Holdings, Inc. (SCPX) — 50 SEC filings. Latest: 8-K (Dec 3, 2025). Includes 41 8-K, 3 10-Q, 2 SC 13G.
View Scorpius Holdings, Inc. on SEC EDGAR
Overview
Scorpius Holdings, Inc. (SCPX) is a publicly traded company tracked on ReadTheFiling. The most recent enriched filing is a 8-K filed on Dec 3, 2025: On December 2, 2025, Scorpius Holdings, Inc. entered into a material definitive agreement and created a direct financial obligation. The company also reported on unregistered sales of equity securities and filed financial statements and exhibits. Scorpius Holdings, Inc. was formerly known as NightHa
Sentiment Summary
Across 50 filings, the sentiment breakdown is: 3 bearish, 47 neutral. The dominant filing sentiment for Scorpius Holdings, Inc. is neutral.
Filing Type Overview
Scorpius Holdings, Inc. (SCPX) has filed 41 8-K, 3 10-Q, 1 10-K, 1 S-1/A, 1 DEF 14A, 1 S-1, 2 SC 13G with the SEC between Aug 2024 to Dec 2025.
Filings by Year
Recent SEC Filings (50)
Risk Profile
Risk Assessment: Of SCPX's 47 recent filings, 3 were flagged as high-risk, 37 as medium-risk, and 7 as low-risk. The overall risk profile suggests moderate risk with a balanced mix of positive and cautionary disclosures.
Financial Highlights
| Metric | Value |
|---|---|
| Revenue | $212,264 |
| Net Income | $(10,714,555) |
| EPS | $(1.16) |
| Debt-to-Equity | N/A |
| Cash Position | $188,914 |
| Operating Margin | N/A |
| Total Assets | $23,585,574 |
| Total Debt | $30,148,342 |
Key Executives
- Jeffrey Wolf
Industry Context
The biomanufacturing sector is capital-intensive and subject to stringent regulatory oversight. Companies often face long development cycles and significant R&D costs. The current environment may see increased consolidation and a focus on operational efficiency due to economic pressures.
Top Tags
material-agreement (20) · financial-obligation (19) · equity-sale (12) · financials (5) · pharmaceuticals (5) · management-change (4) · material-definitive-agreement (4) · corporate-governance (3) · company-name-change (3) · equity-securities (2)
Key Numbers
| Metric | Value | Context |
|---|---|---|
| Revenue | $212,264 | 94% decrease from $3,513,948 in Q1 2024, indicating severe operational decline. |
| Net Loss Attributable to SCPX | $(10,714,555) | More than doubled from $(4,417,549) in Q1 2024, highlighting worsening profitability. |
| Accumulated Deficit | $(297,893,225) | Significant and growing deficit as of March 31, 2025, indicating historical unprofitability. |
| Cash and Cash Equivalents | $188,914 | Critically low cash balance as of March 31, 2025, down from $1,027,997 at December 31, 2024. |
| Loss on Lease Assignment and Termination | $5,733,298 | Major one-time expense in Q1 2025, reflecting significant operational restructuring. |
| Loss on Settlement of Related Party Receivable | $780,000 | Expense from settling a receivable with Elusys Holdings, controlled by the CEO. |
| Shares Outstanding | 61,142,712 | As of August 22, 2025, indicating potential for further dilution given financing needs. |
| Net Loss Per Common Share | $(1.16) | For Q1 2025, compared to $(31.38) in Q1 2024 (adjusted for reverse stock split), showing continued per-share losses. |
| Fiscal Year End | 2024-12-31 | Reporting period for the 10-K |
| Filing Date | 2025-04-30 | Date the 10-K was submitted to the SEC |
| Report Date | 20250307 | Earliest event reported |
| SIC Code | 2834 | Pharmaceutical Preparations industry |
| SEC File Number | 333-283880 | Identifies this specific registration statement with the SEC. |
| IRS Employer Identification No. | 26-2844103 | Company's tax identification number. |
| Share Price Input | 0.005 | Used in warrant valuation for Prefunded Warrant Member |
Frequently Asked Questions
What are the latest SEC filings for Scorpius Holdings, Inc. (SCPX)?
Scorpius Holdings, Inc. has 50 recent SEC filings from Aug 2024 to Dec 2025, including 41 8-K, 3 10-Q, 2 SC 13G. Each filing includes an AI-generated plain-English summary.
What is the overall sentiment of SCPX filings?
Across 50 filings, the sentiment breakdown is: 3 bearish, 47 neutral. The dominant sentiment is neutral.
Where can I find Scorpius Holdings, Inc. SEC filings explained simply?
ReadTheFiling provides AI-powered plain-English summaries of all Scorpius Holdings, Inc. (SCPX) SEC filings, including 10-K annual reports, 10-Q quarterly reports, 8-K current reports, and insider trades.
What are the key financial highlights for Scorpius Holdings, Inc.?
Key financial highlights from Scorpius Holdings, Inc.'s most recent 10-Q include metrics such as revenue, net income, EPS, and debt ratios. Visit the filing detail page for the full breakdown.
What is the investment thesis for SCPX?
The investment thesis for SCPX includes bull, base, and bear case scenarios derived from AI analysis of recent SEC filings.
Who are the key executives at Scorpius Holdings, Inc.?
Key executives identified across Scorpius Holdings, Inc.'s filings include Jeffrey Wolf.
What are the main risk factors for Scorpius Holdings, Inc. stock?
Of SCPX's 47 assessed filings, 3 were flagged high-risk, 37 medium-risk, and 7 low-risk.
What are recent predictions and forward guidance from Scorpius Holdings, Inc.?
Forward guidance and predictions for Scorpius Holdings, Inc. are extracted from SEC filings as they are enriched.